Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Hematology (Amsterdam, Netherlands)|December 8, 2017
Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products - a matched pair analysisStefan Wilop, Rainhardt OsiekaAnticancer Research|May 23, 2002
Interleukin-6 affects melphalan-induced DNA damage and repair in human multiple myeloma cellsThomas Efferth, Ursula Fabry, Rainhardt OsiekaCancer Letters|October 3, 2002
Synergism between rViscumin and cisplatin is not dependent on ERCC-1 expressionOliver Galm, Ursula Fabry, Thomas Efferth, et al.Medizinische Klinik (Munich, Germany : 1983)|June 18, 2003
[HbH disease--a rare differential diagnosis in a patient with anemia and abdominal pain]Ursula Fabry, Elisabeth Kohne, Oliver Galm, et al.Leukemia & Lymphoma|April 7, 2009
CpG island methylation patterns in chronic lymphocytic leukemiaBarbara Seeliger, Stefan Wilop, Rainhardt Osieka, et al.Leukemia & Lymphoma|November 21, 2008
Rituximab-associated changes in platelet count in patients with non-Hodgkin lymphomaStefan Wilop, Oliver Galm, Reyad Dada, et al.Blood|November 29, 2002
SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myelomaOliver Galm, Hirohide Yoshikawa, Manel Esteller, et al.Acta Haematologica|November 6, 2009
Successful treatment of hepatic encephalopathy in a patient with acute lymphoblastic leukemiaReyad Dada, Stefan Wilop, Edgar Jost, et al.Onkologie|June 27, 2009
Cisplatin as single-agent chemotherapy in patients with liver dysfunction due to metastasesStefan Wilop, Reyad Dada, Oliver Galm, et al.Journal of Cancer Research and Clinical Oncology|April 29, 2009
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapyStefan Wilop, Sabine von Hobe, Martina Crysandt, et al.Pageof 2